Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - XBiotech Inc. | f10k_031620p.htm |
| EX-32.2 - EXHIBIT 32.2 - XBiotech Inc. | exh_322.htm |
| EX-32.1 - EXHIBIT 32.1 - XBiotech Inc. | exh_321.htm |
| EX-31.2 - EXHIBIT 31.2 - XBiotech Inc. | exh_312.htm |
| EX-31.1 - EXHIBIT 31.1 - XBiotech Inc. | exh_311.htm |
| EX-21.1 - EXHIBIT 21.1 - XBiotech Inc. | exh_211.htm |
| EX-10.15 - EXHIBIT 10.15 - XBiotech Inc. | exh_1015.htm |
| EX-10.14 - EXHIBIT 10.14 - XBiotech Inc. | exh_1014.htm |
| EX-4.1 - EXHIBIT 4.1 - XBiotech Inc. | exh_41.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
| (1) | Registration Statement (Form S-3 No. 333-213218) of XBiotech Inc., |
| (2) | Registration Statement (Form S-3 No. 333-231849) of XBiotech Inc., and |
| (3) | Registration Statement (Form S-8 No. 333-207476) pertaining to the 2005 Incentive Stock Option Plan and 2015 Equity Incentive Plan of XBiotech Inc.; |
of our report dated March 16, 2020, with respect to the consolidated financial statements of XBiotech Inc. included in this Annual Report (Form 10-K) of XBiotech Inc. for the year ended December 31, 2019.
/s/ Ernst & Young LLP
Austin, Texas
March 16, 2020